S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches

CNS Pharmaceuticals (CNSP) Earnings Date, Estimates & Call Transcripts

$0.31
+0.03 (+10.71%)
(As of 03/1/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

CNSP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CNSP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CNSP Earnings Date and Information

CNS Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 1st, 2024 based off prior year's report dates.

CNS Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/1/2024
Estimated)
------- 
11/14/2023Q3 2023($1.73)($1.08)+$0.65($1.08)--
8/14/2023Q2 2023-($1.04)($1.04)($1.04)--
5/15/2023Q1 2023-($2.59)($2.59)($2.59)--
11/10/2022Q3 2022-($2.70)($2.70)($0.09)--
8/12/2022Q2 2022-($2.70)($2.70)($0.09)--
5/16/2022Q1 2022-($2.10)($2.10)($0.07)--
3/3/2022Q4 2021($4.80)($3.00)+$1.80($0.10)--
11/12/2021Q3 2021($6.30)($4.20)+$2.10($0.14)--
8/12/2021-($4.80)($4.50)+$0.30($0.15)--
5/14/2021Q1($3.60)($4.50)($0.90)($0.15)--












CNS Pharmaceuticals Earnings - Frequently Asked Questions

When is CNS Pharmaceuticals's earnings date?

CNS Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 1st, 2024 based off last year's report dates. Learn more on CNSP's earnings history.

How much profit does CNS Pharmaceuticals generate each year?

CNS Pharmaceuticals (NASDAQ:CNSP) has a recorded net income of -$15.27 million. CNSP has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:CNSP) was last updated on 3/2/2024 by MarketBeat.com Staff